Author: Altamira Therapeutics Ltd.

Posted Date:

April 13, 2026

Altamira Therapeutics Announces Publication Highlighting Potential of RNA Nanoparticles for Disease-Modifying Treatment of Osteoarthritis

Altamira Therapeutics Ltd.

April 13, 2026
Altamira Therapeutics Provides Business Update and Reports Full Year 2025 Financial Results

Altamira Therapeutics Ltd.

March 31, 2026
Altamira Therapeutics Announces Allowance of Japanese Patent Application Covering Bentrio Nasal Spray

Altamira Therapeutics Ltd.

February 13, 2026
Altamira Therapeutics to Present at mRNA-Based Therapeutics Summit

Altamira Therapeutics Ltd.

January 27, 2026